Pricing with confidence in a fear-based market with Scott Leick, RhythmScience

In this episode of If Prices Could Talk, Tracy Dent sits down with Scott Leick, SVP of Finance & Analytics at RhythmScience, and Patrick McCullough, Partner at Holden Advisors, to talk about pricing, analytics, negotiations, and new product launches. We discuss:

  • How to use analytics to replace gut instinct in pricing decisions
  • Lessons from the drug-eluting stent “race to the bottom” on price
  • How to price new tech when the market is uncertain
  • The impact of private equity ownership on purchasing power
  • How to align commercial teams when sellers are under pressure to deliver

About Scott

Scott Leick is the SVP of Finance and Marketing at RhythmScience. He has almost 25 years of experience in pricing at companies from the Fortune 50 to Series A SaaS startups, including executive roles at Medtronic, C.H. Robinson, and Acutus Medical.

Learn more about RhythmScience: https://www.rhythm360.io

Listen on: